Patented Technology from Australia and the USA
Backed by High-Value Insurance Coverage
Autologous Leukocyte-Derived Stem Cells That Enable Multi-System Regeneration
The patented autologous leukocyte-derived stem cell therapy involves extracting white blood cells from the client’s blood and converting them into multi-lineage potential stem cells. This entire process is conducted in a certified GTP laboratory using a fully closed production system, without the addition of antibiotics, growth factors, or any genetic modification. Within just four days, the cells are transformed into the specific types of stem cells needed by the body. The procedure is highly safe, meets both U.S. FDA and Australian TGA standards, and holds patents in both the United States and Australia. It is currently the only legally approved autologous leukocyte-derived stem cell therapy in the world.
Advantages of AMPC Autologous Multi-Lineage Potential Stem Cells
The key advantage that enabled Autologous Multi-Lineage Potential Stem Cells (AMPC) to obtain a U.S. patent lies in their ability to be derived from an individual’s own peripheral blood. Once reinfused into the body, these cells—originally adult leukocytes—can differentiate into various essential cell types, including neural cells, intestinal epithelial cells, blood cells, pancreatic cells, liver cells, and cardiomyocytes.
As human stem cells naturally decline with age, the only safe and effective way to replenish them is through reinfusion of stem cells that can successfully multiply and differentiate within the body. AMPC offers this critical regenerative capability, making it a safe and advanced therapeutic option.
AMPC has the ability to transform into neural cells (ectoderm), osteoblasts and cardiomyocytes (mesoderm), as well as hepatocytes (endoderm). These cells respond to the body’s biochemical signals and autonomously identify and migrate to areas in need of repair through a process known as cellular homing.
This broad differentiation potential allows AMPC to positively impact a wide range of degenerative conditions, including arthritis, leukemia, cardiovascular diseases, kidney diseases, liver disorders, immune-related conditions such as atopic dermatitis, and even stroke.
The cells differentiate naturally within the body without the addition of any growth factors, without genetic modification, and without any risk of carcinogenicity.
